Abstract:Objective To analyze prognostic factors and construct a prognostic model for patients with locally advanced gastric cancer (LAGC) who underwent curative resection.Methods A retrospective analysis was conducted on the clinicopathological data of 186 LAGC patients who underwent curative resection at Affiliated Zhangjiagang Hospital of Soochow University between January 2015 and December 2018. Patients in the training cohort were followed up for 5 years and were subsequently classified into a survival group (n = 112) and a death group (n = 74) according to follow-up outcomes. Multivariable Cox proportional hazards regression analysis was performed to identify prognostic factors for LAGC, and a nomogram model was constructed based on the identified variables.Results Compared with the death group, patients in the survival group were younger, had smaller tumor diameters, a lower proportion of low/poor tumor differentiation, a higher proportion of clinical stage II disease, and lower neutrophil-to-lymphocyte ratios (NLR) (all P < 0.05). Multivariable Cox proportional hazards regression analysis identified older age [H^R = 1.054 (95% CI: 1.014, 1.096) ], larger tumor diameter [H^R = 1.416 (95% CI: 1.117, 1.794) ], clinical stage III disease [H^R = 3.474 (95% CI: 1.671, 7.221) ], and elevated NLR higher[H^R = 2.598 (95% CI: 1.529, 4.414) ] as independent risk factors for prognosis after curative resection in patients with LAGC (all P < 0.05). In contrast, well or moderately differentiated tumors [H^R = 0.339 (95% CI: 0.163, 0.705) ] were identified as a protective factor (P < 0.05). Receiver operating characteristic (ROC) curve analysis showed that the combined detection achieved an area under the curve (AUC) of 0.821, with a sensitivity of 70.3% (95% CI: 0.585, 0.803) and a specificity of 86.6% (95% CI: 0.789, 0.923). Patients in the older age group had lower survival rates than those in the younger age group (P < 0.05). Similarly, patients with larger tumor diameters exhibited lower survival rates compared with those with smaller tumors (P < 0.05). Patients with lowly or moderately differentiated tumors showed higher survival rates than those with high or moderately high differentiation (P < 0.05). Survival was higher in patients with clinical stage II disease compared with stage III (P < 0.05). Additionally, patients with elevated NLR had lower survival rates than those with lower NLR (P < 0.05).Conclusion Age, tumor diameter, tumor differentiation, clinical stage, and NLR are factors affecting the prognosis of LAGC patients. Additionally, the combination of these indicators exhibits higher predictive value for the prognosis of the patients.